Theravance Biopharma
TBPH
#6920
Rank
€0.42 B
Marketcap
Country
8,52 €
Share price
-0.86%
Change (1 day)
1.91%
Change (1 year)
Categories
P/S ratio for Theravance Biopharma (TBPH)
P/S ratio as of March 2025 (TTM): 7.09
According to Theravance Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.60. At the end of 2024 the company had a P/S ratio of 7.32.
P/S ratio history for Theravance Biopharma from 2014 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 7.32 | -24.85% |
| 2023 | 9.75 | -33.78% |
| 2022 | 14.7 | -0.02% |
| 2021 | 14.7 | -7.45% |
| 2020 | 15.9 | -20.88% |
| 2019 | 20.1 | -14.81% |
| 2018 | 23.6 | -75.93% |
| 2017 | 98.1 | 188.12% |
| 2016 | 34.0 | 130.35% |
| 2015 | 14.8 | -64.07% |
| 2014 | 41.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.48 | -79.11% | 🇺🇸 USA |
 | 8.54 | 20.39% | 🇺🇸 USA |
 | 6.10 | -14.02% | 🇺🇸 USA |
 | 2.61 | -63.26% | 🇺🇸 USA |